publication date: Dec. 21, 2010
In this issue:
CMS Allows Medicare Payment for Eloxatin, But Says Review of New Agents Likely;
Gleevec Approved For Pediatric CML;
Peter Boyle Elected IARC Director;
Blackburn Wins BMS Award;
ASCO Recognizes 15 for Leadership in Clinical Oncology, Updates Genetic Testing Recommendations;
Funding Opportunities (8-page issue).
Download (PDF 196KB)
To access this members-only content, please log in.
Institutional subscribers, please log in with your IP
If you're not a subscriber why not join today?
To gain access to the members only content click here
You will be given immediate access to premium content on the site.Click here to join.